Remove 2024 Remove Access Remove Data Remove Medicine
article thumbnail

Argentina Presents Cannabis, Hemp Industry Bill

Cannabis Law Report

.” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. According to Kulfas, the benefits will include: Health rights: supply of medical cannabis to ensure better access to health. ley cáñamo argentina. .”

Hemp 105
article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100
article thumbnail

Khiron Opens First clinic in Europe with Zerenia™ Clinics UK

Cannabis Law Report

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52
article thumbnail

Australia: Medicinal cannabis firm Greenfield MC Global turns to crowdfunding for expansion

Cannabis Law Report

Despite strong prescription growth in Australia and inroads in many jurisdictions abroad, not to mention recreational cannabis legalisation in Canberra which paradoxically may be a threat to the sector , weak investor sentiment has been a tough pill to swallow for medicinal cannabis companies on the ASX. million. .

article thumbnail

Green Light Law Group: Oregon Psilocybin Advisory Board Approves Training and Products Recommendations

Cannabis Law Report

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Programs shall train students on how to proactively make psilocybin services accessible to people with disabilities.

Law 52
article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98